logo-loader

Buds & Duds: Canopy stock soars as it strikes mammoth $3.4B deal to buy Acreage after US federal legalization

Published: 16:38 18 Apr 2019 EDT

Buds of the day are Canopy Growth Corporation (TSE:WEED) (NYSE:CGC), iAnthus Capital Holdings Inc. (CSE:IAN) (OTCMKTS:ITHUF), and duds of the day are Aphria Inc (TSE:APHA), Tilray Inc (NASDAQ:TLRY) (NYSE:APHA). 

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

43 minutes ago